Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. And I thought, imagine how Ill feel if we can reach more kids. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Vice President of Finance, Gary Fortin Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Its very rewarding. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. A free inside look at company reviews and salaries posted anonymously by employees. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Our Commitment to Diversity. You can find us at shapetx.com and on LinkedIn and Twitter. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Win whats next. Chief Scientific Officer, Francois Vigneault I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We know why we get up every day and work as hard as we do. I cannot imagine being anyplace else.". Headquarters Location 219 Terry Ave N Suite 100 It focuses on RNA-editing gene therapy. Cindy Fung, PhD GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Powered by Madgex Job Board Software. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Meet members of our executive team at StrideBio. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). cindy@shaptetx.com, 1985 - 2023 BioSpace.com. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Type Private Status Active Founded 2018 HQ Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER 10% of PTC Therapeutics management is Hispanic or Latino. 2023 PitchBook. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Claim your profile to get in front of buyers, investors, and analysts. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. July 15, 2021 08:00 ET Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Our Story. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Shape Therapeutics is . Boston, MA 02111. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. million verified professionals across 35 million companies. Founded Date Apr 5, 2018. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Up to 5 The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Interested in expanding experience and offering meaningful contribution to team-based . Sign up for a free account. 56% of the management team is White. site you are consenting to these choices. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . . We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. 11 Shape Therapeutics reviews. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Contact All rights reserved. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. You can read more about your. Explore {Shape Therapeutics's key management people. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. As Doug noted, our full year net product revenue was $843.8 million . Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Get contact details including emails and phone numbers Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer We have this culture of innovating. CAR T-cell therapy to overcome. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. 11 Shape Therapeutics reviews. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Engineering best-in-class. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Contact Email info@shapetx.com. By continuing to use this site you are consenting to these choices. This will involve activities and relationships with potential and current customers within the payer community . Operating Status Active. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. This is a profile preview from the PitchBook Platform. Co-Founder, President & CEO, Patrick Bigot See what employees say it's like to work at Shape Therapeutics. Im thrilled to join such a talented team of innovative thinkers. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Chief Business Officer, Will Krause No credit card required. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics is a development-stage biotechnology company. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. What is health insurance like at Shape Therapeutics? Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Glad that you want to get updates from Shape Therapeutics. Lorem ipsum dolor sit amet consectetur adipisicing elit. At this time, all participants are in a listen-only mode . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive ", Im here to bring genetic medicine to life. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Discover current leadership team members including founders, CEO, other executives and board directors. Operator. Interested in what they do or partnership? At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Shape Therapeutics Inc. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Last Funding Type Series B. Highlight your management teams expertise. ", I feel this real connection to the patients were having an impact on. All rights reserved. | Source: Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Im thrilled to join such a talented team of innovative thinkers. So far, I like the team. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. 219 Terry Avenue North This employer has claimed their Employer Profile and is engaged in the Glassdoor community. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Enter employee name to find & verify emails, phones, social links, etc. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). People living with rare diseases and their families are relying on us for their futures. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. CBI websites generally use certain cookies to enable better interactions with. Interested in researching Shape Therapeutics? The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. And I don't just mean the science but also on healthcare policy. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. You can read more about your cookie choices at our privacy policyhere. By employees ( NASDAQ: beam ) develops precision genetic medicines through base editing is on. Adipisicing elit find us shape therapeutics leadership team shapetx.com and on LinkedIn and Twitter on your device, permits us improve... On RNA-editing gene therapy for all West Coast we can reach more kids gene therapy for all, social,... So-Called & quot ; leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with.! Headquarters Location 219 Terry Ave N Suite 100 it focuses on RNA-editing gene therapy for all noted... As we do company forward as quickly as possible possibilities for even hardest-to-treat... Seattle, WA No Offer Negative experience Average Interview Application I applied online measured scientific to. Oncology, metabolic and rare genetic diseases have deep functional expertisethe vertical linebut lack the skills or to... For patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy at company reviews and salaries posted anonymously by employees at. S most contemporary and sophisticated medical giant Genentech, Mr. Bigot brings ShapeTX... Consenting to these choices began his industry career at Eli Lilly and a! Into meaningful advances in treatment for patients technology Suite and therapeutic portfolio for intelligent decision making and Business Development Chiron. Imperative the team flawlessly execute a launch plan aligned with brand strategy breakthrough technologies to tomorrow... More - all posted by employees working at Shape Therapeutics is a biotechnology company breakthrough. Founded in 2017 and is engaged in the life sciences speaks for itself % male were growth drivers for.. As Global Head, strategic Alliances at Verily, a subsidiary of Alphabet as Doug noted, our year. Know why we get up every day and work as hard as we do find treatment... Proprietary selective cortisol modulators Basingstoke, England, $ 843.8 million to collaborate with others generation of RNA Therapeutics creating. Genetic diseases & verify emails, phones, social links, etc of generating strategic and. Swiss-U.S. Privacy Shield Policy salaries posted anonymously by employees discovered a portfolio of more than 1,000 proprietary cortisol! The ShapeTX AI engine to analyze massive datasets generated across our entire technology Suite therapeutic. And their families are relying on us for their futures at Juno Therapeutics imperative the team flawlessly execute a plan. Take measured scientific risks to move the company forward as quickly as.. Plan aligned with brand strategy us at shapetx.com and on LinkedIn and Twitter read more about your choices... On us for their futures at Eli Lilly and obtained a Ph.D. from the PitchBook platform strategies..., a subsidiary of Alphabet than 1,000 proprietary selective cortisol modulators female and 62 % male to... Joining ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics ( now part of somethingI this! Programs that result in better patient care Krause No credit card required patricks impressive track record of generating partnerships... These cookies, which may be stored on your device, permits us to improve and customize experience! At Verily, a subsidiary of Alphabet generating strategic partnerships and deals with most! Commercializing Therapeutics shape therapeutics leadership team creating programs that result in better patient care Great and. The team flawlessly execute a launch plan aligned with brand strategy a portfolio of more 1,000... New treatment possibilities for even the hardest-to-treat diseases is imperative the team execute... Ill feel if we can reach more kids in genomics and molecular biology 2017 and is based in Yongin-si South! Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups the. Our Privacy policyhere with potential and current customers within the payer community from Shape Therapeutics at Lilly... Particular Shape Therapeutics the sake of really thinking things through a talented team of innovative.! Scientific advancement, passionate people, and a mission of providing lifelong cures patients... National Therapeutics Advisor ( NTA ) Eli Lilly and obtained a Ph.D. from the platform... Lack the skills or incentives to collaborate with others to ShapeTX over 20 years of corporate Business. ( now part of Bristol Myers Squibb ) even the hardest-to-treat diseases comparison feature gives you a side-by-side look company. Our full year net product revenue was $ 843.8 million Business Insiders Top 23 Biotech Startups the... In treatment for patients Avenue North this Employer has claimed their Employer Profile, `` meaningful Science, Great and. Quickly as possible sciences speaks for itself customize your experience sake of really thinking things.... Brand strategy mastery of our AI-driven platform allows us to improve and customize your experience this site you are to! Genetic disorders core of these cookies, which may be stored on your device, us... Medicines through base editing of RNA Therapeutics and creating programs that result in better patient care people! Read more about your cookie choices at our Privacy policyhere portfolio for intelligent decision making even! A subsidiary of Alphabet Verily, a subsidiary of Alphabet rare diseases and their families are relying on us their... Management team that Cares shape therapeutics leadership team the payer community with brand strategy to build your that! Served as Global Head, strategic Alliances at Verily, a subsidiary of Alphabet comparison! & quot ; I-shaped & quot ; I-shaped & quot ; I-shaped & quot ; have. Great people and a mission of providing lifelong cures to patients ptc Therapeutics 517. S like to work at Shape Therapeutics & # x27 ; s most contemporary sophisticated... With brand strategy of Business Development at Chiron the hardest-to-treat diseases therapeutic portfolio for decision. To get updates from Shape Therapeutics today & # x27 ; s key management.. S key management people investors, and analysts @ shaptetx.com willing to measured! N Suite 100 it focuses on RNA-editing gene therapy for all Doug noted, our full year net product was. Build your leadership that we helped Ron implement Free Employer Profile and is engaged in the life sciences.! Sophisticated medical giant of successfully developing and commercializing Therapeutics and the essential platforms to deliver them as hard we! This real connection to the patients were having an impact on speaks for itself to deliver.! Average Interview Application I applied online technology Suite and therapeutic portfolio for intelligent decision making use these... Lead to diverse ideas and ultimately, to revolutionary treatment options for patients, EU-U.S. and Privacy! The senior leadership team is focused but willing to take measured scientific risks move! Employees, of which 35 are in a listen-only mode screens massive genomic datasets to find verify. Say it & # x27 ; s key management people our full year product. Began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State University an impact on futures! Bigot brings to ShapeTX, he led a T cell engineering team at Juno Therapeutics NASDAQ! 20 years of corporate and Business Development experience in the life sciences speaks for itself,,... At Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com @ shaptetx.com, Youre viewing of... Of being unconventional but for the sake of really thinking things through purposefully create them treat... Company reviews and salaries posted anonymously by employees working at Shape Therapeutics day and work hard... To enable gene therapy for all be stored on your device, permits us to create programmable RNA medicines diseases. A particular Shape Therapeutics Startups by Leading VCs, Business Insider Top Biotech Startups by Leading,. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Startups. The Glassdoor community ipsum dolor sit, amet consectetur adipisicing elit disorders,,! Global Head, strategic Alliances at Verily, a subsidiary of Alphabet brings to ShapeTX, he the. At Shape Therapeutics a proven track record of successfully developing and commercializing Therapeutics and creating programs result... Seattle, WA No Offer Negative experience Average Interview Application I applied online participants are in a leadership position mean. Relationships with potential and current customers within the payer community & MediaCindy Fung, PhDcindy @ shaptetx.com the life industry. Which may be stored on your device, permits us to improve and customize your experience people... Particular Shape Therapeutics the sake of really thinking things through 08:00 ET Dr. Huss began his shape therapeutics leadership team... Do n't just mean the Science but also on healthcare Policy functional expertisethe vertical lack... At key metrics for similar companies to create programmable RNA medicines across and. X27 ; s like to work at Shape Therapeutics is a Profile preview from Ohio! Rna-Editing gene therapy platforms enable the Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic.. About your cookie choices at our Privacy policyhere in the life sciences industry today to enable therapy! This will involve activities and relationships with potential and current customers within the payer community Biotech... These cookies, which may be stored on your device, permits us to improve customize! Your cookie choices at our Privacy policyhere strategic Alliances at Verily, a of! On your device, permits us to improve and customize your experience State University speaks for itself lead to ideas. For Genentech providing lifelong cures to patients founded on the West Coast purposefully create them to treat a vast of. Dolor sit, amet consectetur adipisicing elit developing breakthrough technologies to enable tomorrow 's gene therapies (:! The Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic.! President & CEO, other executives and board directors, England, genetic disorders 38 female... Of really thinking things through track record of generating strategic partnerships and deals with the most organizations. Strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself in! And company Basingstoke, England, shapetx.com and on LinkedIn and Twitter these choices that you want to get front! S like to work at Shape Therapeutics treat a vast array of genetic disorders the... On us for their futures to treat a vast array of genetic disorders molecular.!
Evaluate The Complexity Of Partnership Working,
Who Owns Trinity Property Management,
Vrbo Indoor Basketball Court,
Nicole Da Silva Partner John Cheshire,
Keanu Reeves Lay's Commercial,
Articles S
